DaVita Inc. (DVA) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for DaVita Inc. (DVA:NYSE), powered by AI.

Current Price
$208.98
P/E Ratio
20.8
Market Cap
15.5B
Sector
Healthcare
What is the DaVita Inc. stock price forecast?

DaVita Inc. is currently trading at $208.98. View real-time AI analysis on Alpha Lenz.

What is DaVita Inc. insider trading activity?

View the latest insider trading data for DaVita Inc. on Alpha Lenz.

What is DaVita Inc.'s P/E ratio?

DaVita Inc.'s P/E ratio is 20.8.

DaVita Inc.

NYSE · DVA
$208.98-0.77(-0.37%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about DaVita Inc.'s future dividend policy...
Alpha Chat Insight

DaVita Inc. trades at a P/E of 20.8 (fair value) with modest ROE of -281.8%.

Ask for details

Company Overview

DaVita Inc. is a prominent player in the healthcare sector, specializing in kidney care services. As a leading provider of dialysis services in the United States, DaVita operates numerous dialysis centers and provides care for patients with chronic kidney failure and end-stage renal disease. The primary function of the company is to deliver life-sustaining dialysis treatments to improve quality of life and extend survival for those affected by kidney-related health issues. DaVita's offerings include hemodialysis and peritoneal dialysis, catering to diverse patient needs. It also engages in ancillary services such as laboratory testing and management services for outpatient services. Recognized for its extensive network and focus on innovation in patient care, DaVita plays a crucial role in the healthcare industry by addressing the growing demand for specialized treatment. With a commitment to clinical excellence and operational efficiency, DaVita contributes significantly to the healthcare system by improving patient outcomes and providing accessible care solutions nationwide.

CEOMr. Javier J. Rodriguez
SectorHealthcare
IndustryMedical Care Facilities
Employees76,000

Company Statistics

FY 2025

Profile

$15.51BMarket Cap
$13.64BRevenue
0.00Shares Out
76,000Employees

Margins

32.25%Gross
19.47%EBITDA
14.74%Operating
9.87%Pre-Tax
7.91%Net

Valuation

20.77P/E
-23.82P/B
1.14EV/Sales
11.11EV/EBITDA
11.84P/FCF

Growth (CAGR)

5.53%Rev 3Yr
3.39%Rev 5Yr
15.28%Op Inc 3Yr
3.61%Op Inc 5Yr
11.34%Net Inc 3Yr
1.64%Net Inc 5Yr

Returns

6.21%ROA
-281.83%ROE
11.08%ROIC

Financial Health

$676.44MCash & Cash Equivalents
$15.65BNet Debt
1408.94%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

DaVita Inc. (ticker: DVA) is a company listed on NYSE in the Healthcare sector (Medical Care Facilities). It has approximately 76,000 employees. Market cap is $15.5B.

The current price is $208.98 with a P/E ratio of 20.77x and P/B of -23.82x.

ROE is -281.83% and operating margin is 14.74%. Annual revenue is $13.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
DaVita Inc. (DVA) Stock Forecast 2026 $208.98 — Price, Financials & Analyst Targets | Alpha Lenz